Young-Hyuck Im
20PUBLICATIONS
114CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (20)
Sort by Publication Date:
|Dec 17, 2025
KEYLYNK-009: Pembrolizumab plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer after Clinical Benefit from First-Line Pembrolizumab plus Chemotherapy.Hope S Rugo, David W Cescon, Mark E Robson
|Dec 01, 2025
Phase Ib/II Study of Zanidatamab in Combination with Tislelizumab and Chemotherapy in First-Line HER2-Positive Gastric/Gastroesophageal Junction Adenocarcinoma.Keun-Wook Lee, Li-Yuan Bai, Minkyu Jung
|Sep 11, 2024
Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update.Sibylle Loibl, Jacek Jassem, Amir Sonnenblick
|Jun 06, 2024
Scalp Cooling in Preventing Persistent Chemotherapy-Induced Alopecia: A Randomized Controlled Trial.Danbee Kang, Juhee Cho, Di Zhao
|Jan 18, 2024
Phase II DORA Study of Olaparib with or without Durvalumab as a Chemotherapy-Free Maintenance Strategy in Platinum-Pretreated Advanced Triple-Negative Breast Cancer.Tira J Tan, Sarah Sammons, Young-Hyuck Im
|Nov 22, 2023
A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer.David W Cescon, John Hilton, Serafin Morales Murilo
Pageof 4
Frequent Collaborators
7 joint publications
Yeon Hee Park
5 joint publications
Ji-Yeon Kim
5 joint publications
Jeong Eon Lee
3 joint publications
Jin Seok Ahn
2 joint publications
Danbee Kang
2 joint publications
Juhee Cho
2 joint publications
Jai Min Ryu
2 joint publications
Hye Ryeon Kim
2 joint publications
Hae Hyun Jung
2 joint publications
Eun Yoon Cho
